Raymond James & Associates’s Protolabs PRLB Stock Holding History
Bought
Maintained
Sold
Other funds holding PRLB
AIM
BCM
NAMA
DGI
TCM
RP
Raymond James & Associates's PRLB Position: Q2 2021 in Review
Raymond James & Associates sold out of Protolabs (PRLB) in Q2 2021, closing a stake of 2,185 shares — an estimated $266K sold.
Raymond James & Associates first reported a position in PRLB in Q2 2013 and held it in 24 quarters. The position peaked at $3.17M in Q1 2016. 273 funds tracked by Wall St. Rank hold PRLB as of Q2 2021.
- Raymond James & Associates reported no remaining Protolabs position as of Q2 2021 after selling out during the quarter.
- Raymond James & Associates sold 2,185 Protolabs shares in Q2 2021, an estimated $266K.
- Raymond James & Associates first reported a position in Protolabs in Q2 2013 and held it in 24 quarters.
- Raymond James & Associates's Protolabs position peaked at $3.17M in Q1 2016.
- 273 funds tracked by Wall St. Rank held Protolabs as of Q2 2021.
Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.